Unique ID issued by UMIN | C000000392 |
---|---|
Receipt number | R000000483 |
Scientific Title | Treatment efficacy of pegintron alpha-2b and rivavirin for chronic hepatitis C patients with genotype 2 and high viral loads based on the dissapearance speed of serum HCV-RNA |
Date of disclosure of the study information | 2012/12/31 |
Last modified on | 2015/08/30 10:47:16 |
Treatment efficacy of pegintron alpha-2b and rivavirin for chronic hepatitis C patients with genotype 2 and high viral loads based on the dissapearance speed of serum HCV-RNA
GLSG,2006,Pegintron
Treatment efficacy of pegintron alpha-2b and rivavirin for chronic hepatitis C patients with genotype 2 and high viral loads based on the dissapearance speed of serum HCV-RNA
GLSG,2006,Pegintron
Japan |
chronic hepatitis C with genotype 2 and high viral loads
Medicine in general | Hepato-biliary-pancreatic medicine |
Others
NO
To evaluate the safety and efficacy of peginterferon alpha-2b and ribavirin therapy for chronic hepatitis C with genotype 2 and high viral loads based on the dissapearance speed of HCV-RNA
Safety,Efficacy
Confirmatory
Pragmatic
Phase IV
virological responses and
predictive factors associated each virological responses
safety, dose reduction and discontinuation
Interventional
Parallel
Non-randomized
Open -no one is blinded
No treatment
4
Treatment
Medicine |
pegintron alpha-2b/rivavirin for 12 weeks for SRVR group
pegintron alpha-2b/rivavirin for 24 weeks for RVR group
pegintron alpha-2b/rivavirin for 48 weeks for LVR group
pegintron alpha-2b/rivavirin for 24 weeks for LVR group
20 | years-old | <= |
75 | years-old | > |
Male and Female
chronic hepatitis C with genotype 2
positive test of HCV-RNA and pretreatment viral load
is more than 100 KIU/mL
negative test of HBsAg
chronic liver disease arising from other etiology
allergy to interferon (IFN)
during pregnancy
severe complications-especially bone marrow, renal,cardiac, or respiratory dysfunction
150
1st name | |
Middle name | |
Last name | Ken Sato |
Gunma University Graduate School of Medicine
Department of Medicine and Molecular Science
3-39-22 Showa, Maebashi, Gunma, Japan
0272-20-8127
satoken@gunma-u.ac.jp
1st name | |
Middle name | |
Last name | Ken Sato |
Gunma University Graduate School of Medicine
Department of Medicine and Molecular Science
3-39-22 Showa, Maebashi, Gunma, Japan
0272-20-8127
satoken@showa.gunma-u.ac.jp
Gunma Liver Study Group (GLSG)
Gunma Liver Study Group (GLSG)
Self funding
Japan
NO
2012 | Year | 12 | Month | 31 | Day |
Published
Completed
2005 | Year | 12 | Month | 25 | Day |
2006 | Year | 01 | Month | 01 | Day |
2011 | Year | 12 | Month | 01 | Day |
2012 | Year | 06 | Month | 01 | Day |
2012 | Year | 06 | Month | 01 | Day |
2012 | Year | 12 | Month | 01 | Day |
2006 | Year | 04 | Month | 02 | Day |
2015 | Year | 08 | Month | 30 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000483
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |